Immunopathology of respiratory infections

Slides:



Advertisements
Similar presentations
Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages
Advertisements

Laboratory diagnosis and biosafety issues of biological warfare agents
C.-S. Lee, J.-H. Lee  Clinical Microbiology and Infection 
Chlamydophila pneumoniae
Gut bacterial microbiota and obesity
Approach to diagnosis of infective endocarditis
The changing epidemiology of severe infections in the ICU
Herpes zoster in non-hospitalized children
Atypical respiratory pathogens
C.-S. Lee, J.-H. Lee  Clinical Microbiology and Infection 
J.-P. Van geertruyden  Clinical Microbiology and Infection 
Hydatid disease Clinical Microbiology and Infection
Successful treatment of Salmonella aortitis with ciprofloxacin
Link between intracellular pathogens and cardiovascular diseases
How to evaluate and predict the ecologic impact of antibiotics: the pharmaceutical industry view from research and development  R. Bax  Clinical Microbiology.
Non-antibiotic strategies for sepsis
How to evaluate and predict the epidemiologic impact of antibiotic use in humans: the pharmacoepidemiologic approach  D. Guillemot  Clinical Microbiology.
In vitro activity, postantibiotic effect and human monocyte activity of grepafloxacin against Legionella species  Jacques Dubois, Claude St-Pierre  Clinical.
Trends in antibiotic prescribing in general internal medicine wards: antibiotic use and indication for prescription  B. Maraha, M. Bonten, H. Fiolet,
Holt Hanne M. , Søgaard Per , Gahrn-Hansen Bente  
Structure of grepafloxacin relative to activity and safety profile
Vector control: a cornerstone in the malaria elimination campaign
Immunotherapy of aspergillosis
Fourth-generation cephalosporins: a review of in vitro activity, pharmacokinetics, pharmacodynamics and clinical utility  Javier Garau, Walter Wilson,
C-3′Quaternary Ammonium Cephems, a New Wave of Cephalosporins
Training for the infectious diseases speciality in Norway
F. Grill, P. Muñoz, R. Jofre, E. Bouza 
Cephalosporins: a pharmacological update
Epidemiology of opportunistic infections in AIDS patients
Laboratory diagnosis and biosafety issues of biological warfare agents
P.M. Keig, E. Ingham, P.A.R. Vandamme, K.G. Kerr 
Comparative in vitro activity of ertapenem against bacterial pathogens isolated from patients with lower respiratory tract infections  P.S. Hicks, B.
Sepsis and neutropenia induced by clozapine
Gastrointestinal and respiratory Mycobacterium avium colonization and development of disseminated infection in HIV-positive patients  Giampietro Nardi,
Uncommon opportunistic fungi: new nosocomial threats
F.L. van de Veerdonk, B.-J. Kullberg, M.G. Netea 
André Bryskier  Clinical Microbiology and Infection 
Evaluation of the effect of interleukin-10 on the multiplication of Mycobacterium avium complex in human macrophages and in C57BL/6 mice  Hilte F. Geerdes-Fenge,
Metagenomics and probiotics
Effect of antioxidants on the immune response of Helicobacter pylori
Laboratory diagnosis of Clostridium difficile disease
S8 – S47 and O50 – O440 Clinical Microbiology and Infection
Interactions between cytomegalovirus and the p53 tumor suppressor gene in atherosclerotic vascular disease  Inge O. Baas, G. Johan A. Offerhaus, Ralph.
G.R. Davies  Clinical Microbiology and Infection 
Pathogenesis of catheter-related infections: lessons for new designs
Community-acquired pneumonia: epidemiologic and clinical consideration
Grepafloxacin: pharmacokinetics and tissue penetration
Pandemic lineages of extraintestinal pathogenic Escherichia coli
Clinical infection services—the Leiden experience
Ethan Rubinstein, Itzhak Levy  Clinical Microbiology and Infection 
Interleukin-18 in Intestinal Inflammation: Friend and Foe?
European guidelines for diagnosis and management of patients with suspected herpes simplex encephalitis  Miles Denton, Kevin G Kerr, Fraser Lewis  Clinical.
Clinical Microbiology and Infection
Empiric therapy of bacterial infections in severe neutropenia
Overview of cefixime use in community-acquired infections
Sanford Chodosh  Clinical Microbiology and Infection 
Granulocyte colony-stimulating factor (G-CSF) and interleukin (IL)-8 in sera from patients with Staphylococcus aureus septicemia  Bo Söderquist, Dan Danielsson,
Facilitating learning and change in physicians: Implications for a system of continuing medical education in Europe  Robert D. Fox  Clinical Microbiology.
Abstracts Clinical Microbiology and Infection
New oral cephalosporins in pediatric community-acquired infections
Dagmar Simon, Luca Borradori, Hans-Uwe Simon 
Susceptibility of multi-drug-resistant Pseudomonas aeruginosa in intensive care units: results from the European MYSTIC study group†   H. Goossens  Clinical.
J.L. Balcázar  Clinical Microbiology and Infection 
Raffaele Del Prete, M. D. , Maria Raffaella Buongiorno, B. Sc
Impact of antibiotic restrictions: the patient's perspective
Fernando Baquero, John F
Localized Mycobacterium avium complex infection in a patient on HAART
CMI readers' survey Clinical Microbiology and Infection
The future of diagnostic bacteriology
Vincent Calvez, Marc Grandadam  Clinical Microbiology and Infection 
Presentation transcript:

Immunopathology of respiratory infections Marie Thérèse Labro  Clinical Microbiology and Infection  Volume 4, Pages 2S1-2S7 (April 1998) DOI: 10.1111/j.1469-0691.1998.tb00689.x Copyright © 1998 European Society of Clinical Infectious Diseases Terms and Conditions

Figure 1 Inflammatory amplification cascade. Once a pathogen has invaded the respiratory tract, neutrophils (PMNs) are recruited and activated. Degranulanon of these cells and oxidant production then initiate an amplification loop as follows. Proteinases (mainly elastase) and reactive oxygen radicals destroy the tissues. Proteinases also exert various detrimental effects such as destruction of the ciliated epithelium and stimulation of mucus secretion which results in decreased mucociliary clearance, enabling bacterial colonization and growth. In addition, by destroying various opsonins (e.g. Ig and iC3b), proteinases impair phagocytosis, thus inhibiting bacterial clearance. Bacterial multiplication (x) in turn generates signals which attract more PMNs to the infection site, thus continuing the cycle. PMN recruitment is also increased by the production of interleukin-8 (IL-8), a chemokine, produced by fibroblasts stimulated with elastase-α1-antitrypsin (α1-AT) complex. ↑=increase; ↓=decrease: + = enhancement; – = inhibition; × = growth. Clinical Microbiology and Infection 1998 4, 2S1-2S7DOI: (10.1111/j.1469-0691.1998.tb00689.x) Copyright © 1998 European Society of Clinical Infectious Diseases Terms and Conditions